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ABSTRACT
Objective: To examine the association between cumu-
lative life course and adult socioeconomic status (SES)
and adult levels of inflammatory risk markers (fibrinogen,
white blood cell count (WBC), C-reactive protein (CRP),
von Willebrand factor (vWF) and an overall inflammatory
score).
Design: Retrospective cohort study.
Setting: 12 681 white and African-American participants
in the Atherosclerosis Risk in Communities (ARIC) study
and two ancillary studies.
Methods: Participants provided information on SES and
place of residence in childhood and young (30–40 years)
and mature (45+) adulthood. Residences were linked to
census data for neighbourhood SES information. Multiple
imputation (MI) was used for missing data. Linear
regression and adjusted geometric means were used to
estimate the effects of SES on inflammatory risk marker
levels.
Results: Graded, statistically significant associations
were observed between greater cumulative life-course
exposure to low education and social class and elevated
levels of fibrinogen and WBC among white participants.
Stronger graded, statistically significant associations were
observed between low adult education, social class and
neighbourhood SES and elevated inflammatory levels.
Associations were weaker and less consistent in African-
Americans. Covariate adjustment attenuated results but
many associations remained strong.
Conclusions: Our results suggest that cumulative
exposure to adverse SES conditions across the life course
and low adult SES are associated with an elevated
systemic inflammatory burden in adulthood. Chronic
systemic inflammation may be one pathway linking low
life-course SES and elevated cardiovascular disease risk.
An inverse association of individual1–3 and con-
textual/neighbourhood4 5 socioeconomic status
(SES) in adulthood with cardiovascular disease
(CVD) has been demonstrated. Low adult SES is
associated with poor health behaviours and unfa-
vourable CVD risk factor profiles.3 5–7 Recent
research has focused on the influence of life-course
SES on CVD8 9: various study designs have been
utilised to examine the impact of SES throughout
the life course on adult cardiovascular health and
several interrelated theories have been posited.10–13
Results support a cumulative model of life-course
risk, wherein the accumulation of adverse psycho-
social and physiological exposures across the life
course is associated with increased CVD.9 14–18
Inquiries into possible mechanisms underlying
such associations suggest a sustained, elevated syste-
mic inflammatory burden may mediate social differ-
ences in CVD. Chronic and systemic inflammatory
upregulation plays a central role in atherosclerosis
and its sequelae.19–23 Lower adult SES is associated
with elevated levels of inflammatory markers such as
fibrinogen, white blood cell count (WBC), C-reactive
protein (CRP) and von Willebrand factor (vWF).24–26
These and other inflammatory markers and cyto-
kines have in turn been linked with CVD.27–34
Atherosclerosis begins earlier in life than previously
suspected.35 SES plausibly affects health behaviours,
nutrition, access to health care, exposure to infection
and stress throughout life, thereby influencing an
individual’s systemic inflammatory burden and CVD
risk.3 7
Early-life SES has been linked with elevated
inflammatory marker levels in other studies36–38 and
in this cohort.39 However, no studies have exam-
ined the cumulative influence of exposure to
adverse SES across life on adult inflammatory
levels. In order to explore cumulative adverse SES
exposure and systemic inflammation as a potential
pathway by which SES and CVD may be linked,
we examined the impact of cumulative life-course
and adult SES (measured at both the individual and
community levels) on adult levels of fibrinogen,
WBC, CRP and vWF and overall inflammatory




ARIC is a prospective study of atherosclerosis in
15 792 men and women aged 45–64 at baseline
(1987–9), sampled from four US communities with
an overall 60% participation rate.40 The Life Course
Socioeconomic Status, Social Context and
Cardiovascular Disease (LC-SES) Study is an
ancillary study that retrospectively collected socio-
economic information from childhood (1930–50)
and early adulthood (1960–80) on 12 681 African-
American and white ARIC participants in 2001–2.41
Individual-level SES and places of residence during
childhood and at ages 30, 40 and 50 were collected
in ARIC and from annual follow-up telephone
interviews.
SES measures
SES was evaluated in childhood (10 years of age),
early adulthood (30–40 years of age) and mature
adulthood (45+ years). Individual-level SES was
evaluated via social class and education; contex-
tual/neighbourhood-level SES was evaluated using
SES indices, described below.
Social class was evaluated utilising a derivation
of Wright’s schema for categorising social class, an
established sociological schema previously exam-
ined in epidemiology.42–44 Participants were
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assigned a class at each time point based on education and items
evaluating ownership, authority and control facets of their job
(table 1). Father’s data were used for childhood; principal
occupation at 30–40 years of age and current/last occupation
were used for young and mature adulthood, respectively.
Homemakers were excluded from social class analyses.
Education was evaluated in childhood and adulthood and
categorised low/middle/high (table 2). In childhood, father’s
education was used; in adulthood, participant’s education was
used.
To evaluate neighbourhood SES, participants’ places of
residence during childhood and adulthood were linked to US
census data (county data for childhood and census tract data for
adulthood).45 Of 12 681 participants, 12 373 had US residences
in childhood. Of these 12 373, 98.5% (12 187) had their
childhood residences successfully linked with US county data.
Linkage rates in young adulthood were lower: 66% for 1960
census data, 76% for 1970 data and 85% for 1980 data. A
neighbourhood SES index was created for each period (table 3)
to evaluate contextual/neighbourhood SES.46
Cumulative social class, education and contextual/neighbour-
hood SES measures were created by summing the number of
times across the life course one was exposed to the lowest
category of SES (table 4).14 47
Physiological covariates and outcomes
CVD risk factors, fibrinogen, vWF and WBC were measured at
baseline.40 Diabetic status was determined by fasting plasma
glucose >126 mg/dl, non-fasting plasma glucose >200 mg/dl,
self-reported history of physician-diagnosed diabetes or current
medication for diabetes.5 40
Haemostasis variables were analysed in citrated samples,48
fibrinogen by the thrombin time titration method and vWF
antigen by enzyme-linked immunosorbent assay.49 Reliability
coefficients were 0.72 for fibrinogen and 0.68 for vWF.50 White
cell counts were determined using automated cell counters
(reliability coefficients 0.96–1.00).
CRP measures were obtained from fasting blood taken from
the 5552 participants in the Dental ARIC study during the
1996–8 ARIC Visit (eligibility required having teeth, no medical
contraindications to periodontal probing and consent).51 CRP
was quantified using ELISA assay (range of detection 0.5–
50 mg/l).52 Intra-plate and inter-plate coefficients of variation
ranged from 0–37.3% and 0–10.6%, respectively.
Statistical methods
Incomplete earlier-life address, education and census data
resulted in high missing data rates for cumulative education
(16.4%), class (28.1%) and neighbourhood SES (36.6%) mea-
sures for the overall cohort. Multiple imputation (MI) was used
to reduce bias.53 Data were considered to be missing at random
(MAR), an assumption that usually holds in self-reported
questionnaire data and when erroneous data tend to have only
a minor impact on estimates.54 55 Multivariate imputation by
chained equations (MICE) was carried out in Stata 8.2 SE
utilising 29 demographic covariates and five imputations of 10
iterations.56
Inflammatory outcomes were log-transformed. Overall
inflammatory burden was assessed using an inflammation score
ranging from 0 to 4 (one point was assigned for each of the four
inflammatory markers with a level above its race/ethnicity-
specific median). This score has been previously utilised and
demonstrated a graded, statistically significant association with
risk of incident diabetes.57 Analyses using CRP or the
inflammatory score as outcomes were limited to the 5022
dental ARIC study participants with early-life SES data.
We initially fitted multi-level models with random intercepts
for each tract or county to account for residual within-area
correlation. However, as they did not significantly improve
model fit, we subsequently used linear regression to examine
the impact of each SES measure on each inflammatory outcome.
One set of race/ethnicity-specific models (model A) adjusted
for age, gender and ARIC centre. A second set (model B)
additionally adjusted for high-density lipoprotein cholesterol
(HDL-C), low-density lipoprotein cholesterol (LDL-C), body
mass index (BMI), hypertension (HTN) and HTN medication,
family history of CVD, diabetes status, alcohol intake, smoking
status and cigarette-years smoked. For cumulative SES mea-
sures, the referent was zero exposures to adverse life-course SES
conditions; for adult SES measures, the referent was highest
SES.
Geometric mean levels of inflammatory markers were
computed for each level of SES by exponentiating parameter
estimates. Statistical interaction between SES and potential
confounders was assessed using partial F tests.58 Tests for linear
trend were run using interval SES variables.
RESULTS
African-American participants had lower scores for adult and
cumulative SES measures, higher mean fibrinogen, CRP and
Table 1 Assignment of a participant’s social class in childhood (via father’s education/occupation) and
young and mature adulthood (based on Wright’s class categorisation) for ARIC participants





Worker class No No No
Middle class Yes No No
No No Yes
– Yes No
Capitalist/expert manager class Yes No Yes
– Yes Yes
*Higher education is some college education or more.
Table 2 Assignment of participants’ education group in childhood and adulthood for ARIC participants
Time point Low education group Middle education group High education group
Childhood 0–8th grade 9th–12th grade Some college or more
Adulthood , High school degree High school degree Some college or more
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vWF levels, and lower mean WBC levels (all p,0.001) than
white participants (table 5). Patterns were similar across gender
groups. Percentages and standard errors are presented for SES
measures as these are composite estimates from five multiply
imputed datasets. Neighbourhood SES categories were based on
race/ethnicity-specific distributions and cannot be directly
compared across race/ethnicity groups.
Cumulative life-course SES, white participants
Among white participants, increasing cumulative life-course
exposure to lower SES conditions for all SES measures was
associated with elevated levels of each adult inflammatory
marker in minimally adjusted models (table 6; vWF results in
supplementary table 1). Graded increments in fibrinogen and
WBC levels were observed with greater adverse SES exposure (p
for trend ,0.01 for individual-level SES measures in minimally
adjusted models).
Greater cumulative exposure to unfavourable SES was
strongly associated with elevated fibrinogen and WBC
(table 6). For example, white participants with three versus
zero life-course exposures to the worker social class group had
geometric mean fibrinogen of 296.3 mg/dl (95% CI: 292.4 to
300.2), versus 283.9 mg/dl (95% CI: 281.8 to 286.1) (p,0.001).
Lower categories of all measures were associated with graded
elevations in the overall inflammatory score (supplementary
table 2). Differences between lowest and highest individual-
level SES categories all attained statistical significance in
minimally adjusted models, suggestive of a greater overall
inflammatory burden (p for trend ,0.01).
While CVD risk factor adjustment attenuated all cumulative
SES-inflammation associations, increasing adverse life-course
exposures remained associated with higher CRP, fibrinogen and
vWF (table 6). For fibrinogen, the associations for the most-
exposed versus least-exposed groups remained statistically
significant in all cumulative SES measures.
Adult SES, white participants
Lower adult SES was strongly associated with elevated
inflammatory levels among white participants (table 6; vWF
results in supplementary table 1). Graded elevations in
inflammatory markers were observed with decreasing SES for
all adult measures (p for trend ,0.001 for fibrinogen and WBC
in minimally adjusted models). For every adult SES measure,
participants in lowest versus highest SES groups had statisti-
cally significantly higher levels of all markers; the sole exception
was for Worker class adults and CRP. As with cumulative SES,
fibrinogen and WBC were strongly associated with adult SES.
Lower categories of all measures were associated with graded
elevations in the overall inflammatory score (supplementary
table 2); differences between lowest and highest SES categories
were all significant in minimally adjusted models. Relative
increments in inflammatory score by SES were similar in size to
those observed within levels of cumulative SES.
CVD risk factor adjustment attenuated most associations
(table 6). However, low education remained significantly
associated with elevated fibrinogen and WBC. Elevated fibrino-
gen also remained significantly associated with lowest social
class and neighbourhood SES. Associations with the inflamma-
tory score were no longer statistically significant after covariate
adjustment, but graded associations remained.
Cumulative SES, African-American participants
Among African-Americans, increasing cumulative exposure to
adverse SES was inconsistently associated with elevated
inflammatory levels (table 7; vWF results in supplementary
table 1). Greater life-course exposure to lower education and
social class was associated with elevated fibrinogen and vWF
(and CRP for social class) in minimally adjusted models; greater
exposure to low-SES neighbourhoods was associated with
elevated CRP and fibrinogen. Associations were weaker and
less consistent among African-American participants than
among white participants. Stepwise, graded elevations in
inflammatory marker levels were not consistently observed by
cumulative SES category, as they were in white participants.
Only slight increments in the overall inflammatory score by
greater exposure to adverse SES conditions were observed
(supplementary table 2).
CVD risk factor adjustment strongly attenuated the cumu-
lative SES-inflammatory marker associations. Moreover, certain
associations were inverted after CVD risk factor adjustment,
with greater exposure being associated with lower inflamma-
tory levels.
Adult SES, African-American participants
Lower adult SES was associated with elevated inflammatory
levels among African-Americans (table 7; vWF results in
supplementary table 1). Patterns were more consistent than
for cumulative SES. Levels of all markers were higher for lowest
versus highest category of all SES measures; graded associations
were observed for fibrinogen and WBC.
The influence of lower adult SES on inflammation was
generally smaller among African-American participants than
white participants. For example, the relative increments in CRP,
Table 3 Contextual/neighbourhood SES index for a participant’s place
of residence at each of the three measured time points (childhood, young
adulthood and mature adulthood) for ARIC participants
Step 1 Compute race-specific z-scores of five US census measures:
(1) Median/mean family income
(2) Median/mean value of owner occupied house
(3) Percentage of residents with high school education
(4) Percentage of residents with college education
(5) Percentage of residents in professional/managerial occupations
Step 2 Sum these five z-scores to create a neighbourhood SES index for that time
Step 3. Categorise each index low/middle/high at the 40th and 75th percentiles (based
on naturally occurring divisions in the distributions)
Table 4 Cumulative life-course social class, education and contextual/
neighbourhood SES measures based on a participant’s SES in childhood
and young and mature adulthood for ARIC participants
Cumulative life-course SES
measure Method of creation and range
Cumulative social class Sum the number of times a participant was in the
worker (lowest) social class category, out of
childhood, young adulthood and mature adulthood.
Range: 0–3
Cumulative education Sum the number of times a participant was in the
low education group, out of participant’s and
father’s education. Range: 0–2
Cumulative neighbourhood SES* Sum the number of times a participant lived in a
low SES category neighbourhood, out of
childhood, young adulthood and mature adulthood.
Range: 0–3
*Example: a participant who was in the low neighbourhood SES group in childhood,
the middle group in young adulthood and the low group in mature adulthood would
have a cumulative neighbourhood SES measure score of 2.
Research report
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fibrinogen, WBC and vWF observed for lowest versus highest
education among African-American participants were 18%, 4%,
0% and 7%, respectively, versus 37%, 6%, 10% and 5% for white
participants, respectively. Low adult SES was most notably
associated with adult fibrinogen, where graded associations
were observed for all adult SES measures (p for trend ,0.05).
Lower adult SES was modestly associated with an elevated
overall inflammatory score among African-Americans (supple-
mentary table 2). Associations were smaller than for white
participants for individual-level measures, but larger for
neighbourhood-level SES (p for trend ,0.05).
As for cumulative SES, CVD risk factor adjustment substan-
tially attenuated (and in some instances inverted) most
associations (table 7).
DISCUSSION
Cumulative life-course and adulthood SES were markedly,
inversely associated with adult inflammatory marker levels
among white people. Fibrinogen and WBC were most strongly
associated with life-course and adult SES; statistically signifi-
cant, linear, graded increments in these markers’ levels were
observed with decreasing SES. CRP and vWF were also inversely
associated with SES, although associations did not consistently
attain statistical significance. Results among African-Americans
were less clear: patterns of association were inconsistent,
particularly in covariate-adjusted models. Adult SES was
generally more strongly associated with inflammatory levels
than life-course SES. Graded, stepwise increments in the overall
inflammatory score observed with worse SES (both cumulative
Table 5 Means and percentage of socioeconomic measures, inflammatory markers and covariates for white and African-American participants
White participants African-American participants
Females (n = 4952) Males (n = 4129) Females (n = 1807) Males (n = 954)
Non-imputed data (age-adjusted) Mean SD Mean SD Mean SD Mean SD
Age (years) 53.7 5.6 54.3 5.6 52.6 5.6 52.8 5.7
HDL-C (mg/dl) 57.8 15.0 43.0 15.0 58.5 16.7 50.4 16.7
LDL-C (mg/dl) 134.5 37.2 139 37.2 137.8 42.4 139.1 42.4
BMI (kg/m2) 26.6 4.8 27.4 4.8 30.9 5.9 28.0 5.9
Diabetes (%) 7.0 26.1 8.4 25.9 17.1 4.2 13.8 37.4
Hypertension (%) 24.3 43.3 26.0 42.6 54.5 5.1 50.4 48.9
Hypertension medication (%) 18.2 38.4 18.0 38.1 43.3 48.0 31.1 48.0
Ethanol intake (g/week) 23.3 84.9 67.9 84.9 9.6 80.6 64.2 80.6
Cigarette-years of smoking 205.5 392.9 424.7 392.9 123.5 314 306.3 314.0
Fibrinogen (mg/l) 297.1 59.3 289.5 59.3 321.8 64.9 300.2 64.9
White blood cell count (61000 cells per 106/l) 6.1 1.8 6.3 1.8 5.5 1.9 5.5 1.9
C-reactive protein (mg/l) 7.6 10.9 4.3 10.9 9.6 14.0 6.3 14.0
von Willebrand factor (%) 109.8 40.8 110.4 40.8 131.2 53.4 126.9 53.4
Inflammatory score (0-4) 1.9 1.2 1.8 1.2 2.1 1.1 1.6 1.1
Multiply imputed data: cumulative life-course SES
measures
% SE % SE % SE % SE
Number of exposures to lowest education group (0-2)
0 45.2 0.7 45.6 0.8 20.2 4.0 18.2 3.1
1 43.6 0.7 42.7 0.8 50.4 2.2 50.3 2.9
2 11.2 0.5 11.7 0.5 29.4 5.0 31.5 4.6
Number of exposures to worker class group (0–3)
0 33.3 1.0 45.3 0.8 21.3 1.1 24.0 1.4
1 23.9 0.9 29.3 0.7 28.3 1.2 28.7 1.5
2 23.3 0.9 15.7 0.6 21.0 1.1 21.7 1.4
3 19.4 0.8 9.8 0.5 29.4 1.3 25.7 1.5
Number of exposures to lowest neighbourhood SES group
(0–3)
0 25.7 0.6 28.7 0.7 21.7 1.0 25.7 1.5
1 34.2 0.7 32.5 0.8 37.3 1.3 37.5 1.6
2 26.2 0.7 24.5 0.7 28.2 1.2 23.5 1.4
3 13.9 0.5 14.4 0.6 12.9 0.9 13.3 1.1
Multiply imputed data: adult SES measures % SE % SE % SE % SE
Educational level
High 33.6 0.7 44.3 0.8 31.6 1.1 33.9 1.5
Middle 51.2 0.7 39.8 0.8 29.8 1.1 25.5 1.4
Low 15.2 0.5 15.9 0.6 38.6 1.2 40.7 1.6
Social class
Capitalist/expert manager 23.5 0.7 44.4 0.8 19.1 1.0 31.8 1.5
Middle 38.2 0.8 33.7 0.7 35.8 1.2 32.8 1.5
Worker 38.3 0.8 21.9 0.6 45.1 0.0 36.0 1.6
Neighbourhood SES
High 24.8 0.6 25.7 0.7 24.0 1.0 28.7 1.5
Middle 34.4 0.7 34.6 0.8 31.1 1.1 33.6 1.5
Low 40.8 0.7 39.7 0.8 44.9 1.2 37.7 1.6
SD, standard deviation; SE, standard error.
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life-course and adult measures) underline the consistency of the
analytical results, particularly among white people.
Weaker, less consistent associations among African-
Americans may be due to smaller sample size and power.
Also, race/ethnicity-specific SES distributions differed signifi-
cantly; the range of SES levels among African-American
participants was (1) composed of lower SES scores and (2)
narrower than the range among white participants. Potentially
relevant aspects of SES (for example, healthcare access,
experience with racism) were not available. Associations may
be patterned differently by race/ethnicity, influenced by
differential health selection by race/ethnicity or may point to
limitations present in the evaluation of SES among African-
Americans in ARIC.6 46 59
Studies have consistently reported associations between the
number of adverse life-course SES exposures and levels of CVD
risk factors and events.9 Our results support these findings and
further suggest that earlier-life exposures to adverse conditions
are linked to elevated adult inflammation.
A number of mechanisms may plausibly underlie this link.
The fetal origins hypothesis suggests that malnutrition and
other physiological insults during critical developmental periods
may lead to adult metabolic dysfunction associated with pro-
inflammatory states.60 Childhood exposure to adverse SES
conditions during sensitive developmental periods may have
similar effects. Low SES has been associated with adult health
behaviours linked to inflammation,2 7 and life-course SES may
be a strong determinant of adult health behaviours given the
early development of behaviour patterns. Stress, depression
and/or hostility linked to low SES may lead to chronic
activation of the hypothalamic-pituitary-adrenocortical axis,
increased release of corticosteroids, abnormal platelet function
and other conditions.3 Finally, low SES conditions/environments
plausibly increase exposure to potentially pro-inflammatory or
Table 6 Adjusted geometric means and 95% CI for levels of inflammatory biomarkers by cumulative and adult life-course SES measures and p value
for linear trend among white participants
Cumulative life-course SES
measures

























Number of exposures to lowest
education group (0–2)
0 285 (283 to 287) 287 (285 to 288) 5.8 (5.8 to 5.9) 5.9 (5.8 to 5.9) 1.5 (1.4 to 1.7) 1.6 (1.4 to 1.7)
1 289 (288 to 291*) 289 (287 to 290) 6.0 (5.9 to 6.0*) 5.9 (5.9 to 6.0) 1.7 (1.6 to 1.9) 1.7 (1.5 to 1.9)
2 299 (295 to 303*) 292 (288 to 296*) 6.3 (6.2 to 6.5*) 6.0 (5.9 to 6.2*) 2.0 (1.6 to 2.6*) 1.8 (1.4 to 2.3)
p value for trend ,0.0001 0.0054 ,0.0001 0.0014 0.03 0.29
Number of exposures to worker
class group (0–3)
0 284 (282 to 286) 286 (284 to 288) 5.8 (5.8 to 5.9) 5.9 (5.9 to 6.0) 1.4 (1.2 to 1.5) 1.4 (1.2 to 1.6)
1 289 (287 to 292*) 289 (286 to 291) 6.0 (5.9 to 6.1*) 6.0 (5.9 to 6.1) 1.5 (1.3 to 1.8) 1.5 (1.3 to 1.7)
2 290 (287 to 293*) 288 (285 to 291) 6.1 (6.0 to 6.1*) 6.0 (5.9 to 6.0) 1.5 (1.3 to 1.8) 1.4 (1.2 to 1.8)
3 296 (292 to 300*) 292 (288 to 296*) 6.2 (6.1 to 6.3*) 6.1 (6.0 to 6.2) 1.7 (1.3 to 2.1) 1.6 (1.2 to 2.0)
p value for trend ,0.0001 0.02 ,0.0001 0.04 0.11 0.58
Number of exposures to lowest
neighbourhood SES group (0–3)
0 286 (283 to 288) 287 (285 290) 5.9 (5.8 to 5.9) 5.9 (5.8 to 6.0) 1.5 (1.3 to 1.7) 1.5 (1.3 to 1.7)
1 287 (285 to 289) 287 (285 to 289) 5.9 (5.8 to 6.0) 5.9 (5.9 to 6.0) 1.7 (1.6 to 1.9) 1.8 (1.6 to 2.0)
2 290 (287 to 293*) 288 (285 to 290) 6.0 (5.9 to 6.1*) 6.0 (5.9 to 6.0) 1.7 (1.5 to 2.0) 1.6 (1.4 to 1.8)
3 295 (291 to 298*) 293 (289 to 296*) 6.0 (5.9 to 6.1*) 5.9 (5.9 to 6.0) 1.9 (1.5 to 2.3) 1.8 (1.4 to 2.2)
p value for trend ,0.0001 0.11 0.0061 0.57 0.07 0.37
Adult SES measures
Educational level
High 283 (281 to 284) 286 (284 to 288) 5.8 (5.7 to 5.8) 5.9 (5.8 to 5.9) 1.5 (1.3 to 1.6) 1.6 (1.4 to 1.7)
Middle 290 (288 to 291*) 288 (287 to 290) 6.0 (5.9 to 6.0*) 5.9 (5.9 to 6.0) 1.8 (1.6 to 2.0*) 1.7 (1.5 to 1.9)
Low 300 (296 to 303*) 292 (290 to 295*) 6.3 (6.2 to 6.4*) 6.0 (6.0 to 6.1*) 2.0 (1.6 to 2.5*) 1.8 (1.4 to 2.2)
p value for trend ,0.0001 0.0004 ,0.0001 0.0003 0.0011 0.23
Social class
Capitalist/expert manager 283 (281 to 285) 285 (283 to 287) 5.8 (5.8 to 5.9) 5.9 (5.9 to 6.0) 1.5 (1.3 to 1.7) 1.5 (1.4 to 1.7)
Middle 289 (287 to 291*) 289 (287 to 291*) 6.0 (5.9 to 6.0*) 5.9 (5.9 to 6.0) 1.7 (1.6 to 2.0) 1.7 (1.6 to 1.9)
Worker 293 (291 to 295*) 290 (288 to 292*) 6.1 (6.0 to 6.1*) 6.0 (5.9 to 6.0) 1.6 (1.4 to 1.8) 1.5 (1.3 to 1.7)
p value for trend ,0.0001 0.0017 ,0.0001 0.18 0.46 0.76
Neighbourhood SES
High 283 (280 to 285) 286 (284 to 289) 5.8 (5.7 to 5.9) 5.9 (5.8 to 6.0) 1.4 (1.3 to 1.6) 1.6 (1.4 to 1.8)
Middle 287 (285 to 289*) 287 (285 to 289) 5.9 (5.9 to 6.0*) 5.9 (5.9 to 6.0) 1.6 (1.4 to 1.8) 1.6 (1.4 to 1.7)
Low 293 (291 to 295*) 290 (289 to 292*) 6.0 (6.0 to 6.1*) 5.9 (5.9 to 6.0) 1.9 (1.7 to 2.2*) 1.8 (1.6 to 2.0)
p value for trend ,0.0001 0.0096 ,0.0001 0.27 0.0013 0.12
*p,0.05 for the SES measure parameter coefficient.
{Model A adjusts for ARIC Center, age and gender. Model B adjusts for model A covariates and HDL cholesterol, LDL cholesterol, body mass index, hypertension and hypertension
medication, family history of cardiovascular disease, diabetes status, alcohol intake, smoking status and cigarette-years smoked.
{n is number of participants available for analysis of a particular inflammatory response. Specific cell numbers vary by SES measure used.
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infectious agents such as microbial pathogens, ambient air
pollutants and adverse work conditions.61
Childhood contextual SES was evaluated at the county level
while adult contextual SES was evaluated at the census tract
level; the impact of early-life contextual SES is therefore
probably underestimated. Additionally, the cumulative life-
course model utilised assumes that adverse SES exposures have
the same impact regardless of length or timing of exposure and
does not address the potentially differential impact of upward
or downward social mobility.9 Selective survival of healthier
participants, a 60% baseline participation rate and the avail-
ability of CRP only among healthier participants limited the
socioeconomic and health diversity of participants and may
have biased results towards the null. Errors in remembering
early-life SES may also have biased results towards the null.62
Strengths of this study include use of SES measures from
three life epochs, a separate analysis of adult SES, examination
of both individual-level and contextual-level SES and the
availability of multiple inflammatory markers. Additionally,
the use of MI represents a systematic effort to minimise biases
due to missing data.
While the stronger association between adult SES and
inflammation is unsurprising, inflammatory levels were closely
tied to life-course SES. The graded relations between the
number of life-course exposures to low SES and inflammatory
levels suggest that the impact of these exposures is cumulative.
These findings point to a sustained increase in inflammation as
a response to adverse life-course SES, matching the development
of chronic vascular disease in young adulthood and progressing
throughout life.35 Our results suggest a framework linking
adverse life-course SES exposures to end-organ pathology in
Western industrialised countries. These findings have implica-
tions for our understanding of the long-term development and
progression of chronic vascular disease and speak to a need for
Table 7 Adjusted geometric means and 95% CI of inflammatory markers by levels of cumulative life-course and adult SES measures and p values for
linear trend for African-American participants
Cumulative life-course SES measures

























Number of exposures to lowest education
group (0–2)
0 306 (300 to 311) 308 (302 to 314) 5.3 (5.2 to 5.5) 5.3 (5.1 to 5.5) 2.1 (1.5 to 3.1) 2.4 (1.7 to 3.5)
1 306 (303 to 310) 308 (304 to 311) 5.2 (5.1 to 5.3) 5.2 (5.1 to 5.3) 2.0 (1.6 to 2.6) 2.0 (1.6 to 2.5)
2 311 (306 to 316) 308 (303 to 314) 5.3 (5.1 to 5.4) 5.2 (5.1 to 5.3) 2.3 (1.6 to 3.4) 2.0 (1.4 to 3.1)
p for trend 0.14 0.94 0.63 0.29 0.76 0.52
Number of exposures to worker class
group (0–3)
0 300 (295 to 306) 305 (299 to 311) 5.2 (5.1 to 5.4) 5.3 (5.2 to 5.5) 1.9 (1.3 to 2.6) 1.8 (1.2 to 2.6)
1 303 (298 to 308) 305 (300 to 310) 5.2 (5.1 to 5.3) 5.2 (5.1 to 5.4) 1.8 (1.3 to 2.5) 1.8 (1.2 to 2.5)
2 306 (300 to 312) 303 (298 to 309) 5.2 (5.1 to 5.4) 5.2 (5.0 to 5.3) 2.2 (1.5 to 3.3) 2.3 (1.5 to 3.5)
3 314 (309 to 319*) 311 (306 to 317) 5.3 (5.2 to 5.5) 5.2 (5.1 to 5.4) 2.6 (1.8 to 3.9) 2.9 (1.9 to 4.6)
p for trend 0.0002 0.068 0.23 0.60 0.12 0.027
Number of exposures to lowest
neighbourhood SES group (0–3)
0 305 (300 to 310) 307 (302 to 312) 5.3 (5.1 to 5.4) 5.3 (5.2 to 5.4) 1.8 (1.3 to 2.6) 2.3 (1.6 to 3.4)
1 305 (301 to 310) 306 (302 to 311) 5.2 (5.1 to 5.3) 5.2 (5.1 to 5.3) 2.4 (1.7 to 3.3) 2.1 (1.5 to 2.8)
2 311 (306 to 317) 308 (302 to 314) 5.3 (5.1 to 5.4) 5.2 (5.0 to 5.3) 2.1 (1.4 to 3.3) 2.0 (1.3 to 3.0)
3 312 (305 to 320) 313 (305 to 321) 5.3 (5.1 to 5.5) 5.3 (5.1 to 5.5) 2.1 (1.3 to 3.5) 2.0 (1.1 to 3.3)
p for trend 0.029 0.39 0.79 0.66 0.65 0.57
Adult SES measures
Educational level
High 301 (297 to 305) 306 (301 to 310) 5.2 (5.1 to 5.3) 5.3 (5.2 to 5.4) 1.9 (1.5 to 2.5) 2.0 (1.9 to 2.0)
Middle 309 (304 to 313*) 309 (304 to 313) 5.2 (5.1 to 5.3) 5.2 (5.1 to 5.3) 2.3 (1.7 to 3.1) 2.4 (2.3 to 2.5)
Low 312 (308 to 316*) 309 (306 to 314) 5.3 (5.2 to 5.4) 5.2 (5.1 to 5.3) 2.3 (1.7 to 3.1) 2.0 (1.9 to 2.1)
p value for trend 0.0003 0.26 0.43 0.22 0.42 0.68
Social class
Capitalist/expert manager 304 (299 to 309) 305 (300 to 311) 5.2 (5.1 to 5.3) 5.2 (5.1 to 5.3) 2.4 (1.7 to 3.4) 2.4 (2.3 to 2.6)
Middle 303 (299 to 307) 306 (302 to 310) 5.2 (5.1 to 5.3) 5.3 (5.2 to 5.4) 1.7 (1.3 to 2.2) 1.6 (1.5 to 1.6)
Worker 312 (308 to 316*) 310 (306 to 314) 5.3 (5.2 to 5.4) 5.2 (5.1 to 5.3) 2.5 (1.9 to 3.3) 2.6 (2.5 to 2.7)
p value for trend 0.0046 0.15 0.18 0.85 0.63 0.40
Neighbourhood SES
High 305 (300 to 309) 308 (303 to 313) 5.2 (5.1 to 5.3) 5.3 (5.1 to 5.4) 1.7 (1.3 to 2.4) 1.6 (1.1 to 2.2)
Middle 305 (301 to 309) 307 (302 to 311) 5.2 (5.1 to 5.3) 5.2 (5.1 to 5.3) 2.2 (1.6 to 2.9) 2.4 (1.8 to 3.3)
Low 311 (308 to 315*) 309 (305 to 313) 5.3 (5.2 to 5.4) 5.2 (5.1 to 5.3) 2.4 (1.9 to 3.1) 2.3 (1.7 to 3.0)
p value for trend 0.021 0.91 0.28 0.76 0.13 0.089
*p,0.05 for the SES measure parameter coefficient.
{Model A adjusts for ARIC Center, age and gender. Model B adjusts for model A covariates and HDL cholesterol, LDL cholesterol, body mass index, hypertension and hypertension
medication, family history of cardiovascular disease, diabetes status, alcohol intake, smoking status and cigarette-years smoked.
{n is number of participants available for analysis of a particular inflammatory response. Specific cell numbers vary by SES measure used.
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further examination of the earlier-life development of CVD risk
factors and poor health behaviours.
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